Trial of Plasma Exchange for Severe Crescentic IgA Nephropathy (RESCUE)
Randomized Trial of Plasma Exchange as Adjunctive Therapy for Severe Crescentic GlomerUlonephritis of IgA NEphropathy (RESCUE Study)
Sponsor: Peking University First Hospital
Terminated
Due to the rarity and rapid progressive course of the disease, patients were less likely to participate in randomization.
Other terminated trials from Peking University First Hospital
Other Acute Renal Insufficiency trials with similar outcome
A PHASE2/PHASE3 clinical study on Acute Renal Insufficiency and Glomerulonephritis, IGA, this trial is terminated or withdrawn. The trial is conducted by Peking University First Hospital and has accumulated 10 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Dec 2021 — Jul 2024 [monthly]
Terminated PHASE2_PHASE3
-
Nov 2021 — Dec 2021 [monthly]
Terminated PHASE2_PHASE3
Status: Enrolling By Invitation → Terminated
-
Jan 2021 — Nov 2021 [monthly]
Enrolling By Invitation PHASE2_PHASE3
▶ Show 5 earlier versions
-
Apr 2020 — Jan 2021 [monthly]
Enrolling By Invitation PHASE2_PHASE3
-
Sep 2018 — Apr 2020 [monthly]
Enrolling By Invitation PHASE2_PHASE3
-
Jun 2018 — Sep 2018 [monthly]
Enrolling By Invitation PHASE2_PHASE3
-
May 2017 — Jun 2018 [monthly]
Enrolling By Invitation PHASE2_PHASE3
Status: Recruiting → Enrolling By Invitation
-
Jan 2017 — May 2017 [monthly]
Recruiting PHASE2_PHASE3
First recorded
Mar 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Peking University First Hospital
For direct contact, visit the study record on ClinicalTrials.gov .